Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Autoimmune sleep disorders.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Influence of infection on exacerbations of multiple sclerosis.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
The endocannabinoid system and multiple sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.

Pages